Delivery Order SPE2DB22D2009-SPE2DB25FL7XB

Award Date 2/15/25
Potential Completion Date 2/18/25
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,746.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of RIFAMPIN 300 MG CAPSULE 60S, a pharmaceutical product. The contract has an Ultimate Completion Date of July 19, 2024 and a Ceiling Value of $2,746.58. It is a Firm Fixed Price contract, with no set-aside designation. AmerisourceBergen Drug Corp...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of RIFAMPIN 300 MG CAPSULE 60S. The contract has an award value of $28,715.33 and a period of performance through February 12, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,119.71, is for the delivery of RIFAMPIN 300 MG CAPSULE 60S to support federal healthcare programs. The contract has a delivery period through June 3, 2024 and utilizes a Firm Fixed Price pricing type. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award is for the supply of RIFAMPIN 300 MG CAPSULE 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,505.57 Firm Fixed Price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of February 12, 2025 and was awarded on February 11, 2025. There was no set-aside designation for this contract. Amerisourcebergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,981.65 firm-fixed-price delivery order contract is for the supply of 4564885228 - RIFAMPIN 300 MG CAPSULE 60S. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of RIFAMPIN 300 MG CAPSULE 60S. The contract has a ceiling value of $5,497.73 and a period of performance through January 5, 2024. The contract is a Delivery Order placed by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. This contract is not designated as a set-aside. AmerisourceBergen holds...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $3,447.37 for the procurement of 4564640497 - RIFAMPIN 300 MG CAPSULE 60S. The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RIFAMPIN 300 MG CAPSULE 60S. The contract has a firm fixed price of $33,154.85 and a period of performance through January 17, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,273.92 firm fixed-price delivery order is for the supply of RIFAMPIN 150 MG CAPSULE 30S, a prescription medication. The contract has an ultimate completion date of February 4, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,854.50 firm fixed-price delivery order is for the supply of Rifampin 300 mg capsules. The contract has an ultimate completion date of December 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB25FL7XB
    Delivery Order

This federal contract award is for the delivery of RIFAMPIN 300 MG CAPSULE UD 100S to the Defense Logistics Agency (DLA). The contract, worth $4,018.20, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is February 18, 2025. The contract is not designated with a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/17/25, 10:11 AM